Splenic and Nodal Marginal Zone Lymphomas Are Indolent Disorders at High Hepatitis C Virus Seroprevalence with Distinct Presenting Features but Similar Morphologic and Phenotypic Profiles

Cancer

Volumn 100, Issue 1, 2004, Pages 107-115

  Arcaini, Luca ^a   Paulli, Marco ^a   Boveri, Emanuela ^a   Vallisa, Daniele ^b   Bernuzzi, Patrizia ^b   Orlandi, Ester ^a   Incardona, Paolo ^a   Brusamolino, Ercole ^a   Passamonti, Francesco ^a   Burcheri, Sara ^a   Schena, Claudio ^b   Pascutto, Cristiana ^a   Cavanna, Luigi ^b   Magrini, Umberto ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Hospital of Piacenza   (Italy)

Author keywords

Low grade non Hodgkin lymphoma; Marginal zone; Nodal marginal zone lymphoma; Splenic marginal zone lymphoma

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RIBAVIRIN; VINCRISTINE;

ADULT; AGED; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEROLOGY; SEROPREVALENCE; SPLENECTOMY; SPLENIC MARGINAL ZONE LYMPHOMA; SPLENOMEGALY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HEPACIVIRUS; HUMANS; INTERFERONS; LYMPH NODES; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SPLENIC NEOPLASMS; SPLENOMEGALY;

EID: 10744226313     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11893     Document Type: Review

References (19)

1. Jaffe ES, Harris NL, Chan JKC, Stein H, Vardiman JW. Proposed World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues. Am J Surg Pathol. 1997;21:114-121.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization: classification of tumours. Tumours of haematopoietic and lymhoid tissue. Lyon: IARC Press, 2001:135-137.
3. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood. 2000;96:410-419.
4. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101:2489-2495.
5. Thieblemont C, Felman P, Berger F, et al. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma. 2002;3:41-47.
6. Chacón JI, Mollejo M, Muñoz E, et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood. 2002;100:1648-1654.
7. Nathwani BN, Anderson JR, Armitage JO, et al. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. J Clin Oncol. 1999;17:2486-2492.
8. Berger F, Felman P, Thieblemont C, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood. 2000;95:1950-1956.
9. Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood. 2003;101:2464-2472.
10. Thieblemont C, Felman P, Callet-Bauchu E, et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancer Oncol. 2003;4:95-103.
11. Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood. 1994;83:1558-1562.
12. Isaacson PG, Matutes E, Burke M, Catovsky D. The histopathology of splenic lymphoma with villous lymphocytes. Blood. 1994;84:3828-3834.
13. Zuckerman E, Zuckerman T, Levine A, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 1997;127:423-428.
14. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94.
15. Shi SR, Itzkowits SH, Kim YS. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem. 1988;36:317-322.
16. Rosso R, Neiman RS, Paulli M, et al. Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. Hum Pathol. 1995;26:39-46.
17. Campello C, Poli A, Dal MG, Besozzi-Valentini F. Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Infection. 2002;30:7-12.
18. Marasca R, Vaccari P, Luppi M, Zucchini P, Castelli I, Barozzi P, Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol. 2001;159:253-261.
19. Franco V, Florena AM, Stella M, et al. Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes. Cancer. 2001;91:294-301.